QuBiLs-MAS method in early drug discovery and rational drug identification of antifungal agents

References

• H.M. Blumberg, W.R. Jarvis, J.M. Soucie, J.E. Edwards, J.E. Patterson, M.A. Pfaller, M.S. Rangel-Frausto, M.G. Rinaldi, L. Saiman, R.T. Wiblin, and R.P. Wenzel, Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey, Clin. Infect. Dis. 33 (2001), pp. 177–186.
   PubMed Web of Science ®Google Scholar
• G. Maschmeyer, The changing epidemiology of invasive fungal infections: New threats, Int. J. Antimicrob. Agents 27(Suppl. 1) (2006), pp. 3–6.
   PubMed Web of Science ®Google Scholar
• M. Nucci and K.A. Marr, Emerging fungal diseases, Clin. Infect. Dis. 41 (2005), pp. 521–526.
   PubMed Web of Science ®Google Scholar
• J.R. Rees, R.W. Pinner, R.A. Hajjeh, M.E. Brandt, and A.L. Reingold, The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: Results of population-based laboratory active surveillance, Clin. Infect. Dis. 27 (1998), pp. 1138–1147.
   PubMed Web of Science ®Google Scholar
• T.J. Walsh, A. Groll, J. Hiemenz, R. Fleming, E. Roilides, and E. Anaissie, Infections due to emerging and uncommon medically important fungal pathogens, Clin. Microbiol. Infect. 10(Suppl 1) (2004), pp. 48–66.
   PubMed Web of Science ®Google Scholar
• D.A. Dickman, H. Ding, Q. Li, A.M. Nilius, D.J. Balli, S.J. Ballaron, J.M. Trevillyan, M.L. Smith, L.S. Seif, K. Kim, A. Sarthy, R.C. Goldman, J.J. Plattner, and Y.L. Bennani, Antifungal rapamycin analogues with reduced immunosuppressive activity, Bioorg. Med. Chem. Lett. 10 (2000), pp. 1405–1408.
   PubMed Web of Science ®Google Scholar
• R. Gozalbes, J. Galvez, A. Moreno, and R. Garcia-Domenech, Discovery of new antimalarial compounds by use of molecular connectivity techniques, J. Pharm. Pharmacol. 51 (1999), pp. 111–117.
   PubMed Web of Science ®Google Scholar
• Y. Marrero-Ponce, A. Montero-Torres, C.R. Zaldivar, M.I. Veitia, M.M. Perez, and R.N. Sanchez, Non-stochastic and stochastic linear indices of the 'molecular pseudograph's atom adjacency matrix': Application to 'in silico' studies for the rational discovery of new antimalarial compounds, Bioorg. Med. Chem. 13 (2005), pp. 1293–1304.
   PubMed Web of Science ®Google Scholar
• Y. Marrero-Ponce, M. Iyarreta-Veitia, A. Montero-Torres, C. Romero-Zaldivar, C.A. Brandt, P.E. Avila, K. Kirchgatter, and Y. Machado, Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps, J. Chem. Inf. Model. 45 (2005), pp. 1082–1100.
   PubMed Web of Science ®Google Scholar
• J.H. McKie, K.T. Douglas, C. Chan, S.A. Roser, R. Yates, M. Read, J.E. Hyde, M.J. Dascombe, Y. Yuthavong, and W. Sirawaraporn, Rational drug design approach for overcoming drug resistance: Application to pyrimethamine resistance in malaria, J. Med. Chem. 41 (1998), pp. 1367–1370.
   PubMed Web of Science ®Google Scholar
• E. Estrada, A. Pena, and R. Garcia-Domenech, Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach, J. Comput. Aided Mol. Des. 12 (1998), pp. 583–595.
   PubMed Web of Science ®Google Scholar
• E. Estrada, E. Uriarte, A. Montero, M. Teijeira, L. Santana, and E. De Clercq, A novel approach for the virtual screening and rational design of anticancer compounds, J. Med. Chem. 43 (2000), pp. 1975–1985.
   PubMed Web of Science ®Google Scholar
• H. Gonzalez-Diaz, E. Tenorio, N. Castanedo, L. Santana, and E. Uriarte, 3D QSAR Markov model for drug-induced eosinophilia – –theoretical prediction and preliminary experimental assay of the antimicrobial drug G1, Bioorg. Med. Chem. 13 (2005), pp. 1523–1530.
   PubMed Web of Science ®Google Scholar
• P.D. Lyne, Structure-based virtual screening: An overview, Drug. Discov. Today 7 (2002), pp. 1047–1055.
   PubMed Web of Science ®Google Scholar
• R. Todeschini and V. Consonni, Molecular Descriptors for Chemoinformatics, Wiley-VCH, Weinheim, 2009.
   Google Scholar
• M.H.J. Seifert, K. Wolf, and D. Vitt, Virtual high-throughput in silico screening, Biosilico (2003), pp. 143–149.
   Google Scholar
• S.J. Barigye, Y. Marrero-Ponce, F. Pérez-Giménez, and D. Bonchev, Trends in information theory-based chemical structure codification, Mol. Divers. 19 (2014), pp. 305–319.
   Google Scholar
• S.J. Barigye and M.P. Freitas, 2D-Discrete Fourier transform: Generalization of the MIA-QSAR strategy in molecular modeling, Chemom. Intell. Lab. Syst. 143 (2015), pp. 79–84.
   Web of Science ®Google Scholar
• S. Barigye, Y. Marrero-Ponce, Y.M. López, O.M. Santiago, F. Torrens, R.G. Domenech, and J. Galvez, Event-based criteria in GT-STAF information indices: Theory, exploratory diversity analysis and QSPR applications, SAR QSAR Environ Res. 24 (2013), pp. 3–34.
   PubMed Web of Science ®Google Scholar
• S.J. Barigye and M.P. Freitas, Is molecular alignment an indispensable requirement in the MIA-QSAR method?, J. Comput. Chem. 36 (2015), pp. 1748–1755.
   PubMed Web of Science ®Google Scholar
• R. Gollapudy, S. Ajmani, and S.A. Kulkarni, Modeling and interactions of Aspergillus fumigatus lanosterol 14-alpha demethylase 'A' with azole antifungals, Bioorg. Med. Chem. 12 (2004), pp. 2937–2950.
   PubMed Web of Science ®Google Scholar
• V.M. Gokhale and V.M. Kulkarni, Understanding the antifungal activity of terbinafine analogues using quantitative structure–activity relationship (QSAR) models, Bioorg. Med. Chem. 8 (2000), pp. 2487–2499.
   PubMed Web of Science ®Google Scholar
• P. Purushottamachar and V.M. Kulkarni, 3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods, Bioorg. Med. Chem. 11 (2003), pp. 3487–3497.
   PubMed Web of Science ®Google Scholar
• S.K. Pranav, Kumar and V.M. Kulkarni, Insights into the selective inhibition of Candida albicans secreted aspartyl protease: A docking analysis study, Bioorg. Med. Chem. 10 (2002), pp. 1153–1170.
   PubMed Web of Science ®Google Scholar
• F. Fratev and E. Benfenati, 3D-QSAR and molecular mechanics study for the differences in the azole activity against yeastlike and filamentous fungi and their relation to P450DM inhibition. 1. 3-Substituted-4(3H)-quinazolinones, J. Chem. Inf. Model. 45 (2005), pp. 634–644.
   PubMed Web of Science ®Google Scholar
• H. Gonzalez-Diaz, F.J. Prado-Prado, L. Santana, and E. Uriarte, Unify QSAR approach to antimicrobials. Part 1: Predicting antifungal activity against different species, Bioorg. Med. Chem. 14 (2006), pp. 5973–5980.
   PubMed Web of Science ®Google Scholar
• L. Pastor, R. Garcia-Domenech, J. Galvez, S. Wolski, and M.D. Garcia, New antifungals selected by molecular topology, Bioorg. Med. Chem. Lett. 8 (1998), pp. 2577–2582.
   PubMed Web of Science ®Google Scholar
• R. García-Domenech, A. Catalá-Gregori, C. Calabuig, G. Antón-Fos, L. del Castillo, and J. Gálvez, Predicting antifungal activity: A computational screening using topological descriptors, Internet Electron. J. Mol. Des. 7 (2002), pp. 339–350.
   Google Scholar
• S.-W. Chen, Z.-R. Li, and X.-Y. Li, Prediction of antifungal activity by support vector machine approach, J. Mol. Struct. (THEOCHEM) 731 (2005), pp. 73–81.
   Web of Science ®Google Scholar
• Y. Marrero-Ponce, Total and local quadratic indices of the molecular pseudograph′s atom adjacency matrix: Applications to the prediction of physical properties of organic compounds, Molecules 8 (2003), pp. 687–726.
   Web of Science ®Google Scholar
• Y. Marrero-Ponce, Linear indices of the ‘molecular pseudograph's atom adjacency matrix’: Definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors, J. Chem. Inf. Comput. Sci. 44 (2004), pp. 2010–2026.
   PubMedGoogle Scholar
• Y. Marrero-Ponce, A. Meneses-Marcel, J.A. Castillo-Garit, Y. Machado-Tugores, J.A. Escario, A.G. Barrio, D.M. Pereira, J.J. Nogal-Ruiz, V.J. Aran, A.R. Martinez-Fernandez, F. Torrens, R. Rotondo, F. Ibarra-Velarde, and Y.J. Alvarado, Predicting antitrichomonal activity: A computational screening using atom-based bilinear indices and experimental proofs, Bioorg. Med. Chem. 14 (2006), pp. 6502–6524.
   PubMed Web of Science ®Google Scholar
• C.R. García-Jacas, Y. Marrero-Ponce, L. Acevedo-Martínez, S.J. Barigye, J.R. Valdés-Martiní, and E. Contreras-Torres, QuBiLS-MIDAS: A parallel free-software for molecular descriptors computation based on multilinear algebraic maps, J. Comp. Chem. 35 (2014), pp. 1395–1409.
   PubMed Web of Science ®Google Scholar
• C.R. Garcia-Jacas, Y. Marrero-Ponce, S.J. Barigye, J.R. Valdes-Martini, O.M. Rivera-Borroto, and J. Olivero-Verbel, N-linear algebraic maps for chemical structure codification: A suitable generalization for atom-pair approaches?, Curr. Drug Metab. 15 (2014), pp. 441–469.
   PubMed Web of Science ®Google Scholar
• C.R. García-Jacas, L. Aguilera-Mendoza, R. González-Pérez, Y. Marrero-Ponce, L. Acevedo-Martínez, S.J. Barigye, and T. Avdeenko, Multi-server approach for high-throughput molecular descriptors calculation based on multi-linear algebraic maps, Mol. Info. 34 (2015), pp. 60–69.
   PubMed Web of Science ®Google Scholar
• G.M. Casanola-Martin, M.T. Khan, Y. Marrero-Ponce, A. Ather, M.N. Sultankhodzhaev, and F. Torrens, New tyrosinase inhibitors selected by atomic linear indices-based classification models, Bioorg. Med. Chem. Lett. 16 (2006), pp. 324–330.
   PubMed Web of Science ®Google Scholar
• Y. Marrero-Ponce, J.A. Castillo-Garit, E. Olazabal, H.S. Serrano, A. Morales, N. Castanedo, F. Ibarra-Velarde, A. Huesca-Guillen, E. Jorge, A. del Valle, F. Torrens, and E.A. Castro, TOMOCOMD-CARDD, a novel approach for computer-aided 'rational' drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds, J. Comput. Aided Mol. Des. 18 (2004), pp. 615–634.
   PubMed Web of Science ®Google Scholar
• Y. Marrero-Ponce, J.A. Castillo-Garit, E. Olazabal, H.S. Serrano, A. Morales, N. Castanedo, F. Ibarra-Velarde, A. Huesca-Guillen, A.M. Sanchez, F. Torrens, and E.A. Castro, Atom, atom-type and total molecular linear indices as a promising approach for bioorganic and medicinal chemistry: Theoretical and experimental assessment of a novel method for virtual screening and rational design of new lead anthelmintic, Bioorg. Med. Chem. 13 (2005), pp. 1005–1020.
   PubMed Web of Science ®Google Scholar
• Y. Marrero-Ponce, Y. Machado-Tugores, D.M. Pereira, J.A. Escario, A.G. Barrio, J.J. Nogal-Ruiz, C. Ochoa, V.J. Aran, A.R. Martinez-Fernandez, R.N. Sanchez, A. Montero-Torres, F. Torrens, and A. Meneses-Marcel, A computer-based approach to the rational discovery of new trichomonacidal drugs by atom-type linear indices, Curr. Drug Discov. Technol. 2 (2005), pp. 245–265.
   PubMedGoogle Scholar
• Y. Marrero-Ponce, R.M. Marrero, F. Torrens, Y. Martinez, M.G. Bernal, V.R. Zaldivar, E.A. Castro, and R.G. Abalo, Non-stochastic and stochastic linear indices of the molecular pseudograph's atom-adjacency matrix: A novel approach for computational in silico screening and ‘rational’ selection of new lead antibacterial agents, J. Mol. Model. (Online) 12 (2006), pp. 255–271.
   PubMed Web of Science ®Google Scholar
• Y. Marrero-Ponce, R. Medina-Marrero, F. Torrens, Y. Martinez, V. Romero-Zaldivar, and E.A. Castro, Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: A promising approach for modeling of antibacterial activity, Bioorg. Med. Chem. 13 (2005), pp. 2881–2899.
   PubMed Web of Science ®Google Scholar
• M.C. Vega, A. Montero-Torres, Y. Marrero-Ponce, M. Rolon, A. Gomez-Barrio, J.A. Escario, V.J. Aran, J.J. Nogal, A. Meneses-Marcel, and F. Torrens, New ligand-based approach for the discovery of antitrypanosomal compounds, Bioorg. Med. Chem. Lett. 16 (2006), pp. 1898–1904.
   PubMed Web of Science ®Google Scholar
• M.A.M. Alho, Y. Marrero-Ponce, S.J. Barigye, A. Meneses-Marcel, Y.M. Tugores, A. Montero-Torres, A. Gómez-Barrio, J.J. Nogal, R.N. García-Sánchez, and M.C. Vega, Antiprotozoan lead discovery by aligning dry and wet screening: Prediction, synthesis, and biological assay of novel quinoxalinones, Bioorg. Med. Chem. 22 (2014), pp. 1568–1585.
   PubMed Web of Science ®Google Scholar
• J.A. Castillo-Garit, Y. Marrero-Ponce, S.J. Barigye, R. Medina-Marrero, M.G. Bernal, J.M. de la Vega, F. Torrens, V.J. Arán, F. Pérez-Giménez, and R. García-Domenechd, In silico antibacterial activity modeling based on the TOMOCOMD-CARDD approach, J. Braz. Chem. Soc. 26 (2015), pp. 1218–1226.
   Web of Science ®Google Scholar
• P.M. Bedi, M.P. Mahajan, and V.K. Kapoor, Amidine derived 1,3-diazabuta-1,3-dienes as potential antibacterial and antifungal agents, Bioorg. Med. Chem. Lett. 14 (2004), pp. 3821–3824.
   PubMed Web of Science ®Google Scholar
• T.G. Brayman and J.W. Wilks, Sensitive assay for antifungal activity of glucan synthase inhibitors that uses germ tube formation in Candida albicans as an end point, Antimicrob. Agents Chemother. 47 (2003), pp. 3305–3310.
   PubMed Web of Science ®Google Scholar
• A. Bryskier, Novelties in the field of anti-infective compounds in 1999, Clin. Infect. Dis. 31 (2000), pp. 1423–1466.
   PubMed Web of Science ®Google Scholar
• V. Buchta, M. Pour, P. Kubanova, L. Silva, I. Votruba, M. Voprsalova, R. Schiller, H. Fakova, and M. Spulak, In vitro activities of 3-(halogenated phenyl)-5-acyloxymethyl- 2,5-dihydrofuran-2-ones against common and emerging yeasts and molds, Antimicrob. Agents Chemother. 48 (2004), pp. 873–878.
   PubMed Web of Science ®Google Scholar
• J.M. Bueno, J.C. Cuevas, J.M. Fiandor, S. Garcia-Ochoa, and F. Gomez de las Heras, Antifungal sordarins. Synthesis and structure-activity relationships of 3',4'-fused dioxolane and dioxane derivatives, Bioorg. Med. Chem. Lett. 12 (2002), pp. 121–124.
   PubMed Web of Science ®Google Scholar
• A. Carta, G. Paglietti, and M.E. Rahbar Nikookar, P. Sanna, L. Sechi, and S. Zanetti, Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity, Eur. J. Med. Chem. 37 (2002), pp. 355–366.
   PubMed Web of Science ®Google Scholar
• K.V. Clemons and D.A. Stevens, Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis, Antimicrob. Agents Chemother. 41 (1997), pp. 200–203.
   PubMed Web of Science ®Google Scholar
• M. Debono and R.S. Gordee, Antibiotics that inhibit fungal cell wall development, Annu. Rev. Microbiol. 48 (1994), pp. 471–497.
   PubMed Web of Science ®Google Scholar
• M. Del Poeta, W.A. Schell, C.C. Dykstra, S. Jones, R.R. Tidwell, A. Czarny, M. Bajic, A. Kumar, D. Boykin, and J.R. Perfect, Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents, Antimicrob. Agents Chemother. 42 (1998), pp. 2495–2502.
   PubMed Web of Science ®Google Scholar
• M. Del Poeta, W.A. Schell, C.C. Dykstra, S.K. Jones, R.R. Tidwell, A. Kumar, D.W. Boykin, and J.R. Perfect, In vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazoles, Antimicrob. Agents Chemother. 42 (1998), pp. 2503–2510.
   PubMed Web of Science ®Google Scholar
• D.W. Denning, Echinocandins and pneumocandins – –A new antifungal class with a novel mode of action, J. Antimicrob. Chemother. 40 (1997), pp. 611–614.
   PubMed Web of Science ®Google Scholar
• J.M. Dominguez, V.A. Kelly, O.S. Kinsman, and M.S. Marriott, F. Gomez de las Heras, and J.J. Martin, Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts, Antimicrob. Agents Chemother. 42 (1998), pp. 2274–2278.
   PubMed Web of Science ®Google Scholar
• H. Ebiike, M. Masubuchi, P. Liu, K. Kawasaki, K. Morikami, S. Sogabe, M. Hayase, T. Fujii, K. Sakata, H. Shindoh, Y. Shiratori, Y. Aoki, T. Ohtsuka, and N. Shimma, Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2, Bioorg. Med. Chem. Lett. 12 (2002), pp. 607–610.
   PubMed Web of Science ®Google Scholar
• S. Emami, M. Falahati, A. Banifatemi, and A. Shafiee, Stereoselective synthesis and antifungal activity of (Z)-trans-3-azolyl-2-methylchromanone oxime ethers, Bioorg. Med. Chem. 12 (2004), pp. 5881–5889.
   PubMed Web of Science ®Google Scholar
• B. Favre and N.S. Ryder, Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents, Antimicrob. Agents Chemother. 40 (1996), pp. 443–447.
   PubMed Web of Science ®Google Scholar
• J.M. Fostel and P.A. Lartey, Emerging novel antifungal agents, Drug. Discov. Today 5 (2000), pp. 25–32.
   PubMed Web of Science ®Google Scholar
• H. Goker, D.W. Boykin, and S. Yildiz, Synthesis and potent antimicrobial activity of some novel 2-phenyl or methyl-4H-1-benzopyran-4-ones carrying amidinobenzimidazoles, Bioorg. Med. Chem. 13 (2005), pp. 1707–1714.
   PubMed Web of Science ®Google Scholar
• V.M. Gokhale and V.M. Kulkarni, Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations, J. Comput. Aided Mol. Des. 14 (2000), pp. 495–506.
   PubMed Web of Science ®Google Scholar
• K. Hata, J. Kimura, H. Miki, T. Toyosawa, M. Moriyama, and K. Katsu, Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis, Antimicrob. Agents Chemother. 40 (1996), pp. 2243–2247.
   PubMed Web of Science ®Google Scholar
• E. Herreros, M.J. Almela, S. Lozano, F. Gomez de las Heras, and D. Gargallo-Viola, Antifungal activities and cytotoxicity studies of six new azasordarins, Antimicrob. Agents Chemother. 45 (2001), pp. 3132–3139.
   PubMed Web of Science ®Google Scholar
• E. Herreros, C.M. Martinez, M.J. Almela, M.S. Marriott, F.G. De Las Heras, and D. Gargallo-Viola, Sordarins: In vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi, Antimicrob. Agents Chemother. 42 (1998), pp. 2863–2869.
   PubMed Web of Science ®Google Scholar
• Y. Kamai, T. Harasaki, T. Fukuoka, S. Ohya, K. Uchida, H. Yamaguchi, and S. Kuwahara, In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent, Antimicrob. Agents Chemother. 46 (2002), pp. 367–370.
   PubMed Web of Science ®Google Scholar
• J.K. Khan, H. Montaseri, M. Poglod, H.Z. Bu, Z. Zuo, S.M. Salama, M. Daneshtalab, and R.G. Micetich, Interspecies comparison of pharmacokinetics of the novel triazole antifungal agent SYN-2869 and its derivatives, Antimicrob. Agents Chemother. 44 (2000), pp. 910–915.
   PubMed Web of Science ®Google Scholar
• I. Kubo, P. Xiao, and K. Fujita, Antifungal activity of octyl gallate: Structural criteria and mode of action, Bioorg. Med. Chem. Lett. 11 (2001), pp. 347–350.
   PubMed Web of Science ®Google Scholar
• B. Lal, V.G. Gund, N.B. Bhise, and A.K. Gangopadhyay, Mannich reaction: An approach for the synthesis of water soluble mulundocandin analogues, Bioorg. Med. Chem. 12 (2004), pp. 1751–1768.
   PubMed Web of Science ®Google Scholar
• B. Lal, V.G. Gund, A.K. Gangopadhyay, S.R. Nadkarni, V. Dikshit, D.K. Chatterjee, and R. Shirvaikar, Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity, Bioorg. Med. Chem. 11 (2003), pp. 5189–5198.
   PubMed Web of Science ®Google Scholar
• S. Li, Z. Zhang, A. Cain, B. Wang, M. Long, and J. Taylor, Antifungal activity of camptothecin, trifolin, and hyperoside isolated from Camptotheca acuminata, J. Agric. Food Chem. 53 (2005), pp. 32–37.
   PubMed Web of Science ®Google Scholar
• S.N. Lopez, M.V. Castelli, S.A. Zacchino, J.N. Dominguez, G. Lobo, J. Charris-Charris, J.C. Cortes, J.C. Ribas, C. Devia, A.M. Rodriguez, and R.D. Enriz, In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall, Bioorg Med Chem 9 (2001), pp. 1999–2013.
   PubMed Web of Science ®Google Scholar
• S.M. Mandala, R.A. Thornton, J. Milligan, M. Rosenbach, M. Garcia-Calvo, H.G. Bull, G. Harris, G.K. Abruzzo, A.M. Flattery, C.J. Gill, K. Bartizal, S. Dreikorn, and M.B. Kurtz, Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase, J. Biol. Chem. 273 (1998), pp. 14942–14949.
   PubMed Web of Science ®Google Scholar
• S.M. Mandala, R.A. Thornton, M. Rosenbach, J. Milligan, M. Garcia-Calvo, H.G. Bull, and M.B. Kurtz, Khafrefungin, a novel inhibitor of sphingolipid synthesis, J. Biol. Chem. 272 (1997), pp. 32709–32714.
   PubMed Web of Science ®Google Scholar
• K. Masubuchi, T. Okada, M. Kohchi, T. Murata, M. Tsukazaki, O. Kondoh, T. Yamazaki, Y. Satoh, Y. Ono, T. Tsukaguchi, K. Kobayashi, N. Ono, T. Inoue, I. Horii, and N. Shimma, Synthesis and antifungal activities of novel 1,3-beta-d-glucan synthase inhibitors. Part 2, Bioorg. Med. Chem. Lett. 11 (2001), pp. 1273–1276.
   PubMed Web of Science ®Google Scholar
• M. Masubuchi, H. Ebiike, K. Kawasaki, S. Sogabe, K. Morikami, Y. Shiratori, S. Tsujii, T. Fujii, K. Sakata, M. Hayase, H. Shindoh, Y. Aoki, T. Ohtsuka, and N. Shimma, Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase, Bioorg. Med. Chem. 11 (2003), pp. 4463–4478.
   PubMed Web of Science ®Google Scholar
• M. Masubuchi, K. Kawasaki, H. Ebiike, Y. Ikeda, S. Tsujii, S. Sogabe, T. Fujii, K. Sakata, Y. Shiratori, Y. Aoki, T. Ohtsuka, and N. Shimma, Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 1, Bioorg. Med. Chem. Lett. 11 (2001), pp. 1833–1837.
   PubMed Web of Science ®Google Scholar
• M. Matsumoto, K. Ishida, A. Konagai, K. Maebashi, and T. Asaoka, Strong antifungal activity of SS750, a new triazole derivative, is based on its selective binding affinity to cytochrome P450 of fungi, Antimicrob. Agents Chemother. 46 (2002), pp. 308–314.
   PubMed Web of Science ®Google Scholar
• G. Menozzi, L. Merello, P. Fossa, S. Schenone, A. Ranise, L. Mosti, F. Bondavalli, R. Loddo, C. Murgioni, V. Mascia, P. La Colla, and E. Tamburini, Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles, Bioorg. Med. Chem. 12 (2004), pp. 5465–5483.
   PubMed Web of Science ®Google Scholar
• S. Moreau, M. Varache-Lembege, S. Larrouture, D. Fall, A. Neveu, G. Deffieux, J. Vercauteren, and A. Nuhrich, (2-Arylhydrazonomethyl)-substituted xanthones as antimycotics: Synthesis and fungistatic activity against Candida species, Eur. J. Med. Chem. 37 (2002), pp. 237–253.
   PubMed Web of Science ®Google Scholar
• N.H. Nam, S. Sardari, M. Selecky, and K. Parang, Carboxylic acid and phosphate ester derivatives of fluconazole: Synthesis and antifungal activities, Bioorg. Med. Chem. 12 (2004), pp. 6255–6269.
   PubMed Web of Science ®Google Scholar
• K. Nimura, Y. Niwano, S. Ishiduka, and R. Fukumoto, Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan, Int. J. Antimicrob. Agents 18 (2001), pp. 173–178.
   PubMed Web of Science ®Google Scholar
• Y. Niwano, N. Kuzuhara, Y. Goto, Y. Munechika, H. Kodama, K. Kanai, M. Yoshida, T. Miyazaki, and H. Yamaguchi, Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections, Int. J. Antimicrob. Agents 12 (1999), pp. 221–228.
   PubMed Web of Science ®Google Scholar
• P. Panneerselvam, R.R. Nair, G. Vijayalakshmi, E.H. Subramanian, and S.K. Sridhar, Synthesis of Schiff bases of 4-(4-aminophenyl)-morpholine as potential antimicrobial agents, Eur. J. Med. Chem. 40 (2005), pp. 225–229.
   PubMed Web of Science ®Google Scholar
• C.A. Quesnelle, P. Gill, M. Dodier, and D. St Laurent, M. Serrano-Wu, A. Marinier, A. Martel, C.E. Mazzucco, T.M. Stickle, J.F. Barrett, D.M. Vyas, and B.N. Balasubramanian, Sordaricin antifungal agents, Bioorg. Med. Chem. Lett. 13 (2003), pp. 519–524.
   PubMed Web of Science ®Google Scholar
• C.K. Ryu, H.Y. Kang, Y.J. Yi, K.H. Shin, and B.H. Lee, Synthesis and antifungal activities of 5/6-arylamino-4,7-dioxobenzothiazoles, Bioorg. Med. Chem. Lett. 10 (2000), pp. 1589–1591.
   PubMed Web of Science ®Google Scholar
• D.J. Sheehan, C.A. Hitchcock, and C.M. Sibley, Current and emerging azole antifungal agents, Clin. Microbiol. Rev. 12 (1999), pp. 40–79.
   PubMed Web of Science ®Google Scholar
• C.E. Stephens, F. Tanious, S. Kim, W.D. Wilson, W.A. Schell, J.R. Perfect, S.G. Franzblau, and D.W. Boykin, Diguanidino and ‘reversed’ diamidino 2,5-diarylfurans as antimicrobial agents, J. Med. Chem. 44 (2001), pp. 1741–1748.
   PubMed Web of Science ®Google Scholar
• J.S. Tkacz and B. DiDomenico, Antifungals: What's in the pipeline, Curr. Opin. Microbiol. 4 (2001), pp. 540–545.
   PubMed Web of Science ®Google Scholar
• N. Tsuchimori, R. Hayashi, N. Kitamoto, K. Asai, T. Kitazaki, Y. Iizawa, K. Itoh, and K. Okonogi, In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum, Antimicrob. Agents Chemother. 46 (2002), pp. 1388–1393.
   PubMed Web of Science ®Google Scholar
• J.M. Urbina, J.C. Cortes, A. Palma, S.N. Lopez, S.A. Zacchino, R.D. Enriz, J.C. Ribas, and V.V. Kouznetzov, Inhibitors of the fungal cell wall. Synthesis of 4-aryl-4-N-arylamine-1-butenes and related compounds with inhibitory activities on beta(1–3) glucan and chitin synthases, Bioorg. Med. Chem. 8 (2000), pp. 691–698.
   PubMed Web of Science ®Google Scholar
• M.L. Vargas, M.V. Castelli, V.V. Kouznetsov, G.J. Urbina, S.N. Lopez, M. Sortino, R.D. Enriz, J.C. Ribas, and S. Zacchino, In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers, Bioorg. Med. Chem. 11 (2003), pp. 1531–1550.
   PubMed Web of Science ®Google Scholar
• I. Yalcin, I. Oren, O. Temiz, and E.A. Sener, QSARs of some novel isosteric heterocyclics with antifungal activity, Acta Biochim. Pol. 47 (2000), pp. 481–486.
   PubMed Web of Science ®Google Scholar
• A. Yotsuji, K. Shimizu, H. Araki, K. Fujimaki, N. Nishida, R. Hori, N. Annen, S. Yamamoto, H. Hayakawa, H. Imaizumi, Y. Watanbe, and H. Narita, T-8581, a new orally and parenterally active triazole antifungal agent: In vitro and in vivo evaluations, Antimicrob. Agents Chemother. 41 (1997), pp. 30–34.
   PubMed Web of Science ®Google Scholar
• Y.Z. Zhang, X. Sun, D.J. Zeckner, R.K. Sachs, W.L. Current, and S.H. Chen, 8-Amido-Bearing pseudomycin B (PSB) analogue: Novel antifungal agents, Bioorg. Med. Chem. Lett. 11 (2001), pp. 123–126.
   PubMed Web of Science ®Google Scholar
• S.Y. Ablordeppey, P. Fan, S. Li, A.M. Clark, and C.D. Hufford, Substituted indoloquinolines as new antifungal agents, Bioorg. Med. Chem. 10 (2002), pp. 1337–1346.
   PubMed Web of Science ®Google Scholar
• A.K. Saha, L. Liu, R.L. Simoneaux, M.J. Kukla, P. Marichal, and F. Odds, Novel antifungals based on 4-substituted imidazole: a combinatorial chemistry approach to lead discovery and optimization, Bioorg. Med. Chem. Lett. 10 (2000), pp. 2175–2178.
   PubMed Web of Science ®Google Scholar
• D. Barrett, A. Tanaka, K. Harada, H. Ohki, E. Watabe, K. Maki, and F. Ikeda, Synthesis and biological activity of novel macrocyclic antifungals: Acylated conjugates of the ornithine moiety of the lipopeptidolactone FR901469, Bioorg. Med. Chem. Lett. 11 (2001), pp. 479–482.
   PubMed Web of Science ®Google Scholar
• A. Bryskier, Novelties in the field of anti-infectives in 1997, Clin. Infect. Dis. 27(1998), pp. 865–883.
   PubMed Web of Science ®Google Scholar
• A. Martinez, S. Ferrer, I. Santos, E. Jimenez, J. Sparrowe, J. Regadera, F.G. De Las Heras, and D. Gargallo-Viola, Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats, Antimicrob. Agents Chemother. 45 (2001), pp. 3304–3309.
   PubMed Web of Science ®Google Scholar
• M.H. Serrano-Wu and D.R. St Laurent, C.E. Mazzucco, T.M. Stickle, J.F. Barrett, D.M. Vyas, and B.N. Balasubramanian, Oxime derivatives of sordaricin as potent antifungal agents, Bioorg. Med. Chem. Lett. 12 (2002), pp. 943–946.
   PubMed Web of Science ®Google Scholar
• G. Turan-Zitouni, Z.A. Kaplancikli, M.T. Yildiz, P. Chevallet, and D. Kaya, Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H -1,2,4-triazole derivatives, Eur. J. Med. Chem. 40 (2005), pp. 607–613.
   PubMed Web of Science ®Google Scholar
• Y.M. Na, M. Le Borgne, F. Pagniez, G. Le Baut, and P. Le Pape, Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives, Eur. J. Med. Chem. 38 (2003), pp. 75–87.
   PubMed Web of Science ®Google Scholar
• The Merck Index, Chapman & Hall, New York, 1996.
   Google Scholar
• J. Ruiz-Herrera and G. San-Blas, Chitin synthesis as target for antifungal drugs, Curr. Drug Targets Infect. Disord. 3 (2003), pp. 77–91.
   PubMedGoogle Scholar
• L. Pauling, The Nature of Chemical Bond, Cornell University Press, Ithaca, NY, 1939.
   Google Scholar
• STATISTICA, version. 6.0, Statsoft.
   Google Scholar
• P. Baldi, S. Brunak, Y. Chauvin, C.A. Andersen, and H. Nielsen, Assessing the accuracy of prediction algorithms for classification: An overview, Bioinformatics 16 (2000), pp. 412–424.
   PubMed Web of Science ®Google Scholar
• M. Randić, Resolution of ambiguities in structure-property studies by use of orthogonal descriptors, J. Chem. Inf. Comput. Sci. 31 (1991), pp. 311–320.
   Google Scholar
• M. Randić, Orthogonal molecular descriptors, New J Chem 15 (1991), pp. 517–525.
   Web of Science ®Google Scholar
• M. Randić, Correlation of enthalpy of octanes with orthogonal connectivity indices, J. Mol. Struct. (Theochem) 233 (1991), pp. 45–59.
   Google Scholar
• E. Estrada and E. Uriarte, Recent advances on the role of topological indices in drug discovery research, Curr. Med. Chem. 8 (2001), pp. 1573–1588.
   PubMed Web of Science ®Google Scholar
• E. Estrada, S. Vilar, E. Uriarte, and Y. Gutierrez, In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives, J. Chem. Inf. Comput. Sci. 42 (2002), pp. 1194–1203.
   PubMedGoogle Scholar
• S. Wold and L. Erikson, Chemometric methods in molecular design, in Chemometric Methods in Molecular Design, H. van de Waterbeemd, ed., VCH Publishers, Weinheim, 1995, pp. 309–318.
   Google Scholar
• A. Golbraikh and A. Tropsha, Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection, Mol. Divers. 5 (2002), pp. 231–243.
   PubMed Web of Science ®Google Scholar
• J. Loeffler and D.A. Stevens, Antifungal drug resistance, Clin. Infect. Dis. 36 (2003), pp. S31–S41.
   PubMed Web of Science ®Google Scholar
• J.D. Nosanchuk, Current status and future of antifungal therapy for systemic mycoses, Recent Patents Anti-Infective Drug Discov. 1 (2006), pp. 75–84.
   PubMedGoogle Scholar